Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Befiradol hydrochloride (NLX-112 hydrochloride) 是一种具有选择性的5-羟色胺 1A (5-HT)1A 受体激动剂,具有抗焦虑活性。Befiradol hydrochloride 抑制突变ATXN3聚集。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,490 | 现货 | ||
5 mg | ¥ 3,790 | 现货 | ||
10 mg | ¥ 5,390 | 现货 | ||
25 mg | ¥ 8,130 | 现货 | ||
50 mg | ¥ 10,900 | 现货 | ||
100 mg | ¥ 14,700 | 现货 |
产品描述 | Befiradol hydrochloride (NLX-112 hydrochloride) is a selective 5-hydroxytryptamine 1A (5-HT)1A receptor agonist with anxiolytic activity.Befiradol hydrochloride inhibits mutant ATXN3 aggregation. |
体内活性 |
Befiradol hydrochloride (F13640 hydrochloride; NLX-112 hydrochloride) decreases the activity of dorsal raphe serotonergic neurons when administered intravenously at doses ranging from 0.2 to 18.2 μg/kg, with an effective dose (ED50) of 0.69 μg/kg, i.v. At the same dosage range, it enhances the firing rate of 80% of the medial prefrontal cortex (mPFC) pyramidal neurons, with an ED50 of 0.62 μg/kg, i.v.[1] Befiradol hydrochloride (0.04-0.63 mg/kg; i.p.) dose-dependently decreases extracellular 5-HT in the hippocampus and mPFC.[1] Befiradol hydrochloride (0.01-2.5 mg/kg; i.p.) dose-dependently increases extracellular DA in mPFC, an effect dependent on the activation of postsynaptic 5-HT1A receptors in mPFC. Local perfusion of Befiradol hydrochloride in mPFC (1-1000 μM) also increases extracellular DA in a concentration-dependent manner.[1] |
别名 | NLX-112 hydrochloride, F 13640 hydrochloride |
分子量 | 430.32 |
分子式 | C20H23Cl2F2N3O |
CAS No. | 2436760-81-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 43.03 mg/mL (100 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.3239 mL | 11.6193 mL | 23.2385 mL | 58.0963 mL |
5 mM | 0.4648 mL | 2.3239 mL | 4.6477 mL | 11.6193 mL | |
10 mM | 0.2324 mL | 1.1619 mL | 2.3239 mL | 5.8096 mL | |
20 mM | 0.1162 mL | 0.581 mL | 1.1619 mL | 2.9048 mL | |
50 mM | 0.0465 mL | 0.2324 mL | 0.4648 mL | 1.1619 mL | |
100 mM | 0.0232 mL | 0.1162 mL | 0.2324 mL | 0.581 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Befiradol hydrochloride 2436760-81-3 GPCR/G Protein Neuroscience 5-HT Receptor NLX-112 hydrochloride Befiradol Hydrochloride F-13640 Hydrochloride NLX112 Hydrochloride F 13640 Hydrochloride F 13640 hydrochloride F13640 Hydrochloride NLX 112 Hydrochloride NLX-112 Hydrochloride Inhibitor inhibitor inhibit